Patents by Inventor Patrick Boyaval

Patrick Boyaval has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230332183
    Abstract: The present invention relates to a method for transforming a strain of the Lactococcus genus through natural competence. The present invention further relates to strains obtained or obtainable by said method. The present invention also relates to a method for identifying a strain of the Lactococcus genus which is transformable through natural competence.
    Type: Application
    Filed: February 22, 2023
    Publication date: October 19, 2023
    Inventors: Christophe Fremaux, Philippe Horvath, Patrick Boyaval, Pascal Hols, David Blandine, Amandine Radziejwoski, Laetitia Fontaine, Frederic Toussaint
  • Patent number: 10640778
    Abstract: The present invention relates to the use of one or more cas genes for modulating resistance in a cell against a target nucleic acid or a transcription product thereof.
    Type: Grant
    Filed: August 4, 2016
    Date of Patent: May 5, 2020
    Assignee: DUPONT NUTRITION BIOSCIENCES APS
    Inventors: Rodolphe Barrangou, Patrick Boyaval, Christophe Fremaux, Philippe Horvath, Dennis Romero
  • Publication number: 20200087686
    Abstract: The present invention relates to a method for transforming a strain of the Lactococcus genus through natural competence. The present invention further relates to strains obtained or obtainable by said method. The present invention also relates to a method for identifying a strain of the Lactococcus genus which is transformable through natural competence.
    Type: Application
    Filed: December 19, 2017
    Publication date: March 19, 2020
    Inventors: Christophe Fremaux, Philippe Horvath, Patrick Boyaval, Pascal Hols, David Blandine, Amandine Radziejwoski, Laetitia Fontaine, Frederic Toussaint
  • Patent number: 10307445
    Abstract: The invention relates to bacterial strains having an outstanding ability to produce menaquinone and to applications thereof.
    Type: Grant
    Filed: September 21, 2015
    Date of Patent: June 4, 2019
    Assignee: DuPont Nutrition Bioscience ApS
    Inventors: Pascal Fourcassie, Patrick Boyaval, Philippe Horvath
  • Patent number: 10066233
    Abstract: The present invention relates to the use of one or more cas genes for modulating resistance in a cell against a target nucleic acid or a transcription product thereof.
    Type: Grant
    Filed: August 25, 2006
    Date of Patent: September 4, 2018
    Assignee: DUPONT NUTRITION BIOSCIENCES APS
    Inventors: Rodolphe Barrangou, Patrick Boyaval, Christophe Fremaux, Philippe Horvath, Dennis Romero
  • Patent number: 9951342
    Abstract: The present invention provides methods and compositions related to modulating the resistance of a cell against a target nucleic acid or a transcription product thereof. In some preferred embodiments, the present invention provides compositions and methods for the use of one or more cas genes or proteins for modulating the resistance of a cell against a target nucleic acid or a transcription product thereof. In some embodiments, the present invention provides methods and compositions that find use in the development and use of strain combinations and starter culture rotations. In additional embodiments, the present invention provides methods for labelling and/or identifying bacteria. In some preferred embodiments, the present invention provides methods for the use of CRISPR loci to determine the potential virulence of a phage against a cell and the use of CRISPR-cas to modulate the genetic sequence of a phage for increased virulence level.
    Type: Grant
    Filed: December 15, 2014
    Date of Patent: April 24, 2018
    Assignee: DUPONT NUTRITION BIOSCIENCES APS
    Inventors: Rodolphe Barrangou, Christophe Fremaux, Phillippe Horvath, Dennis Romero, Patrick Boyaval
  • Patent number: 9879269
    Abstract: The present invention relates to the use of one or more cas genes for modulating resistance in a cell against a target nucleic acid or a transcription product thereof.
    Type: Grant
    Filed: June 6, 2012
    Date of Patent: January 30, 2018
    Assignee: DUPONT NUTRITION BIOSCIENCES APS
    Inventors: Rodolphe Barrangou, Patrick Boyaval, Philippe Horvath, Christophe Fremaux, Dennis A. Romero
  • Publication number: 20170280742
    Abstract: Use of a yeast capable of producing ethanol and acetic acid by fermentation of a carbohydrate, in a method for the fermentation of cocoa beans, is disclosed.
    Type: Application
    Filed: August 27, 2015
    Publication date: October 5, 2017
    Inventors: PASCAL FOURCASSIE, PATRICK BOYAVAL, CLAIRE BONARD
  • Publication number: 20170037416
    Abstract: The present invention relates to the use of one or more cas genes for modulating resistance in a cell against a target nucleic acid or a transcription product thereof.
    Type: Application
    Filed: August 4, 2016
    Publication date: February 9, 2017
    Applicant: DUPONT NUTRITION BIOSCIENCES APS
    Inventors: Rodolphe Barrangou, Patrick Boyaval, Christophe Fremaux, Philippe Horvath, Dennis Romero
  • Patent number: 9243254
    Abstract: The present invention relates to peptides, nucleic acids and methods for transforming a bacterium belonging to the Streptococcus genus by natural competence and their use in the food and feed industry.
    Type: Grant
    Filed: January 23, 2014
    Date of Patent: January 26, 2016
    Assignee: DUPONT NUTRITION BIOSCIENCES APS
    Inventors: Patrick Boyaval, Christophe Fremaux, Pascal Hols, Laetitia Fontaine, Philippe Horvath
  • Publication number: 20160008411
    Abstract: The invention relates to bacterial strains having an outstanding ability to produce menaquinone and to applications thereof.
    Type: Application
    Filed: September 21, 2015
    Publication date: January 14, 2016
    Inventors: Pascal Fourcassie, Patrick Boyaval, Philippe Horvath
  • Publication number: 20150093473
    Abstract: The present invention provides methods and compositions related to modulating the resistance of a cell against a target nucleic acid or a transcription product thereof. In some preferred embodiments, the present invention provides compositions and methods for the use of one or more cas genes or proteins for modulating the resistance of a cell against a target nucleic acid or a transcription product thereof. In some embodiments, the present invention provides methods and compositions that find use in the development and use of strain combinations and starter culture rotations. In additional embodiments, the present invention provides methods for labelling and/or identifying bacteria. In some preferred embodiments, the present invention provides methods for the use of CRISPR loci to determine the potential virulence of a phage against a cell and the use of CRISPR-cas to modulate the genetic sequence of a phage for increased virulence level.
    Type: Application
    Filed: December 15, 2014
    Publication date: April 2, 2015
    Inventors: Rodolphe Barrangou, Christophe Fremaux, Phillippe Horvath, Dennis Romero, Patrick Boyaval
  • USE
    Publication number: 20140199767
    Abstract: The present invention relates to the use of one or more cas genes for modulating resistance in a cell against a target nucleic acid or a transcription product thereof.
    Type: Application
    Filed: August 6, 2013
    Publication date: July 17, 2014
    Inventors: Rodolphe Barrangou, Patrick Boyaval, Christophe Fremaux, Philippe Horvath, Dennis Romero
  • Publication number: 20140134295
    Abstract: The present invention relates to peptides, nucleic acids and methods for transforming a bacterium belonging to the Streptococcus genus by natural competence and their use in the food and feed industry.
    Type: Application
    Filed: January 23, 2014
    Publication date: May 15, 2014
    Inventors: Patrick Boyaval, Christophe Fremaux, Pascal Hols, Laetitia Fontaine, Philippe Horvath
  • Patent number: 8663655
    Abstract: The present invention relates to peptides, nucleic acids and methods for transforming a bacterium belonging to the Streptococcus genus by natural competence and their use in the food and feed industry.
    Type: Grant
    Filed: June 23, 2010
    Date of Patent: March 4, 2014
    Assignee: Dupont Nutrition Biosciences APS
    Inventors: Patrick Boyaval, Christophe Fremaux, Pascal Hols, Laetitia Fontaine, Philippe Horvath
  • Use
    Publication number: 20130011828
    Abstract: The present invention relates to the use of one or more cas genes for modulating resistance in a cell against a target nucleic acid or a transcription product thereof.
    Type: Application
    Filed: June 6, 2012
    Publication date: January 10, 2013
    Inventors: Rodolphe Barrangou, Patrick Boyaval, Christophe Fremaux, Philippe Horvath, Dennis Romero
  • Publication number: 20120129264
    Abstract: The present invention relates to peptides, nucleic acids and methods for transforming a bacterium belonging to the Streptococcus genus by natural competence and their use in the food and feed industry.
    Type: Application
    Filed: June 23, 2010
    Publication date: May 24, 2012
    Applicant: DANISCO A/S
    Inventors: Patrick Boyaval, Christophe Fremaux, Pascal Hols, Laetitia Fontaine, Philippe Horvath
  • Publication number: 20120020927
    Abstract: The invention relates to bacterial strains having an outstanding ability to produce menaquinone and to applications thereof.
    Type: Application
    Filed: April 15, 2010
    Publication date: January 26, 2012
    Applicant: DANISCO A/S
    Inventors: Pascal Fourcassie, Patrick Boyaval, Philippe Horvath
  • Publication number: 20110002889
    Abstract: The present invention provides methods and compositions related to modulating the resistance of a cell against a target nucleic acid or a transcription product thereof. In some preferred embodiments, the present invention provides compositions and methods for the use of one or more cas genes or proteins for modulating the resistance of a cell against a target nucleic acid or a transcription product thereof. In some embodiments, the present invention provides methods and compositions that find use in the development and use of strain combinations and starter culture rotations. In additional embodiments, the present invention provides methods for labelling and/or identifying bacteria. In some preferred embodiments, the present invention provides methods for the use of CRISPR loci to determine the potential virulence of a phage against a cell and the use of CRISPR-cas to modulate the genetic sequence of a phage for increased virulence level.
    Type: Application
    Filed: February 29, 2008
    Publication date: January 6, 2011
    Inventors: Rodolphe Barrangou, Christophe Fremaux, Philippe Horvath, Dennis Romero, Patrick Boyaval
  • Use
    Publication number: 20100093617
    Abstract: The present invention relates to the use of one or more cas genes for modulating resistance in a cell against a target nucleic acid or a transcription product thereof.
    Type: Application
    Filed: August 25, 2006
    Publication date: April 15, 2010
    Inventors: Rodolphe Barrangou, Patrick Boyaval, Christophe Fremaux, Philippe Horvath, Dennis Romero